Literature DB >> 23354678

Comparison of seven commercial enzyme-linked immunosorbent assays for the detection of anti-diphtheria toxin antibodies.

A A Zasada1, W Rastawicki, K Śmietańska, N Rokosz, M Jagielski.   

Abstract

Determination of immune status of patients to diphtheria toxin is based mainly on the results of commercially available ELISA kits. The aim of the present study was to compare the results obtained by ELISAs from seven different manufacturers: Mikrogen, Immunolab, Sekisui Virotech, NovaTec, Virion\Serion, IBL International and Euroimmun. All assays were performed according to the manufacturers' instructions. The concentrations of the anti-diphtheria toxin antibodies in 72 serum samples were calculated on the basis of curves constructed from standards supplied by manufacturers and the new reference material-International Standard for Diphtheria Antitoxin (10/262). The repeatability and reproducibility of all the ELISA kits tested were good. Number of sera with concentrations of the anti-diphtheria toxin antibodies below the WHO-recommended level of protection (0.1 IU/ml) were dependent on the ELISA used: Mikrogen, 20/72 samples (27.7%); Immunolab, 11/72 samples (15.3%); Sekisui Virotech, 0/72 samples (0%); NovaTec 18/72 samples (25.0%); Serion 12/72 samples (16.7%); IBL International, 7/72 samples (9.7 %); and Euroimmun, 17/72 samples (23.6%). However, the results obtained in particular ELISAs, with the exception of Sekisui Virotech, were much more consistent when the concentrations of the anti-diphtheria toxin antibodies in 72 sera measured by using curves constructed from the International Standard 10/262. The data obtained clearly demonstrated that manufacturer-dependent differences between anti-diphtheria IgG ELISA kits exist. The differences in recommendations accepted by the individual manufacturers together with differences shown in our studies in sensitivity greatly affect the clinical interpretation of results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354678     DOI: 10.1007/s10096-013-1823-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

Review 1.  The changing epidemiology of diphtheria in the vaccine era.

Authors:  A Galazka
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

2.  Technical and diagnostic performance of five commercial anti-diphtheria toxoid IgG enzyme-linked immunosorbent assay kits.

Authors:  A Faruq; L Dadson; H Cox; F Alcock; A R Parker
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

3.  Practice parameter for the diagnosis and management of primary immunodeficiency.

Authors:  Francisco A Bonilla; I Leonard Bernstein; David A Khan; Zuhair K Ballas; Javier Chinen; Michael M Frank; Lisa J Kobrynski; Arnold I Levinson; Bruce Mazer; Robert P Nelson; Jordan S Orange; John M Routes; William T Shearer; Ricardo U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  2005-05       Impact factor: 6.347

4.  Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

5.  Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid.

Authors:  Pieter G M van Gageldonk; Christina von Hunolstein; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

6.  Seroprevalence of diphtheria immunity among injured adults in Austria.

Authors:  S Marlovits; R Stocker; A Efstratiou; K Broughton; A Kaider; V Vécsei; G Wiedermann; H Kollaritsch
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

7.  Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000.

Authors:  J Mossong; L Putz; Z Shkedy; F Schneider
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

Review 8.  Immunization against diphtheria with special emphasis on immunization of adults.

Authors:  A M Galazka; S E Robertson
Journal:  Vaccine       Date:  1996-06       Impact factor: 3.641

Review 9.  Diphtheria in the former Soviet Union: reemergence of a pandemic disease.

Authors:  C R Vitek; M Wharton
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

10.  Diphtheria in the postepidemic period, Europe, 2000-2009.

Authors:  Karen S Wagner; Joanne M White; Irina Lucenko; David Mercer; Natasha S Crowcroft; Shona Neal; Androulla Efstratiou
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

View more
  8 in total

1.  Diphtheria in Lao PDR: Insufficient Coverage or Ineffective Vaccine?

Authors:  Naphavanh Nanthavong; Antony P Black; Phonethipsavanh Nouanthong; Chanthasone Souvannaso; Keooudomphone Vilivong; Claude P Muller; Sylvie Goossens; Fabrice Quet; Yves Buisson
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

2.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

3.  Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.

Authors:  Aleksandra A Zasada; Waldemar Rastawicki; Natalia Rokosz; Marek Jagielski
Journal:  BMC Infect Dis       Date:  2013-11-19       Impact factor: 3.090

Review 4.  Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.

Authors:  Frederic Brosseron; Marius Krauthausen; Markus Kummer; Michael T Heneka
Journal:  Mol Neurobiol       Date:  2014-02-25       Impact factor: 5.590

5.  Successful seroconversion against diphtheria and tetanus induced through maternal vaccination in a region of Colombia.

Authors:  Doracelly Hincapie-Palacio; Adriana Echeverri; Cristina Hoyos; Felipe Vargas-Restrepo; Marta Ospina; Seti Buitrago; Jesús Ochoa
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31

6.  Leveraging serology to titrate immunisation programme functionality for diphtheria in Madagascar.

Authors:  Solohery L Razafimahatratra; Arthur Menezes; Amy Wesolowski; Lala Rafetrarivony; Simon Cauchemez; Richter Razafindratsimandresy; Aina Harimanana; Tania Crucitti; Jean Marc Collard; C J E Metcalf
Journal:  Epidemiol Infect       Date:  2022-01-13       Impact factor: 2.451

7.  Characteristics of Dysregulated Proinflammatory Cytokines and Cognitive Dysfunction in Late-Life Depression and Amnestic Mild Cognitive Impairment.

Authors:  Jing Nie; Yuan Fang; Ying Chen; Aisikeer Aidina; Qi Qiu; Lu Zhao; Xiang Liu; Lin Sun; Yun Li; Chuwen Zhong; Yuan Li; Xia Li
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

8.  Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization.

Authors:  Laura María Rivera-Santamaría; Doracelly Hincapié-Palacio; Jesús Ochoa; Felipe Vargas-Restrepo; Marta C Ospina; Seti Buitrago-Giraldo
Journal:  Vaccines (Basel)       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.